Spiru - Grow Spirulina At Home

Spiru专注于开发、保护和推出一种新型的消费者生物技术系统，能够每天增加新鲜螺旋藻的供应量。螺旋藻是一种蓝绿藻营养食品，被认为是世界上营养最密集的食品之一，含有高浓度的抗氧化剂、β-胡萝卜素、铁、蛋白质以及一系列维生素和矿物质。第二次，更严重的新冠肺炎疫情预计将在明年在英国夺走多达120,000人的生命。因此，公共卫生部门将承受巨大压力，因此，积极管理健康和我们随后的免疫功能可以在应对这一挑战方面发挥重要作用。尽管据估计，新冠肺炎疫苗可能会在2021年年中准备就绪，但人们仍在担心如此仓促的开发过程的安全性，以及病毒的变异性和疫苗随后的效力。据报道，自疫情爆发以来，全球营养食品市场的需求增长了20%，除了需求的转变，新冠肺炎还削弱了严重依赖进口营养食品的英国食品供应链。这不仅突出了英国衍生营养产品的机会，而且更明显地表明了对这种产品的需求。螺旋藻已经被证明具有抗病毒、抗炎的特性，这些特性被认为可以提高免疫功能。因此，日常食用螺旋藻可以有效抵御未来爆发的新冠肺炎疫情，减少肺组织炎症，降低肺炎的风险，肺炎是新冠肺炎相关死亡的最常见原因。螺旋藻是一种受欢迎的营养食品，通常作为粉末购买，添加到果汁和冰沙中，但从中国(大部分供应来源)干燥并运往英国的过程使其营养价值降低了50%。SPIRU回应了新冠肺炎之后对营养食品需求的急剧增长，提供了一种基于英国的解决方案，该解决方案保留了100%的可用营养素，并且不依赖于脆弱的食品供应链。它将与不断扩大的国内种植市场高度相关，并将在其整个生命周期内解决食品行业的生产、运输、烹饪和垃圾处理排放问题。SPIRU将在循环经济中设计，尽可能使用生物塑料部件和无污染的工艺，并将产生净积极的环境影响。推出一种可持续的、用户友好的产品，可以用实验室规模螺旋藻培养系统的一小部分成本来制造，将是该项目的一个关键挑战，需要深入的研究、产品开发和测试。

Spiru focuses on the development, protection and launch of a novel consumer biotechnology system, capable of growing daily servings of fresh spirulina, a blue-green algae nutraceutical that is recognised as one of the world's most nutrient-dense foods, containing high concentrations of antioxidants, beta-Carotene, iron, protein, and an array of vitamins and minerals.A second, more severe COVID-19 outbreak is expected to claim as many as 120,000 lives in the UK by next year. The public health sector would consequently be under immense pressure and, therefore, the active management of health and our subsequent immune function could play a major role in addressing this challenge. While it is estimated that a COVID-19 vaccine could be ready by mid-2021, there are ongoing concerns with the safety of such a rushed development process, as well as the mutability of the virus and subsequent efficacy of the vaccine. The global nutraceutical market is reported to have seen a demand increase of 20% since the pandemic began, and in addition to this demand shift, COVID-19 has weakened the UK's food supply chains that heavily rely on importing nutritional foods. This not only highlights an opportunity for a UK-derived nutraceutical product, but more evidently signifies the _need_ for such a product.Spirulina has been shown to have anti-viral, anti-inflammatory properties which are thought to boost immune function. Daily spirulina consumption could therefore serve as an effective barrier against future COVID-19 outbreaks, reducing lung tissue inflammation and lowering the risk of pneumonia, the most common cause of COVID-19-related deaths.Spirulina is a popular nutraceutical, most commonly purchased as a powder and added to juices and smoothies, but the process of drying and shipping to the UK from China (where most of the supply originates) reduces its nutritional value by up to 50%. Spiru responds to the sharp increase in demand for nutraceuticals following COVID-19, offering a UK-based solution which retains 100% of available nutrients and does not depend on vulnerable food supply chains. It will be highly relevant in the expanding grow-at-home market, and will address the food industry's production, transport, cooking and waste disposal emissions throughout its lifetime.Spiru will be designed within the circular economy, using bioplastic components and non-polluting processes where possible, and will have a net positive environmental impact. Launching a sustainable, user-friendly product, which can be manufactured at a fraction of the cost of lab-scale spirulina cultivation systems, will be a key challenge of this project, requiring intensive research, product development and testing.